In humans, serum levels of NLRP3 are elevated in patients with PD and are associated with greater total and phosphorylated α-synuclein levels [48], thus providing further evidence of the interplay between the inflammasome and PD pathology. The gene discussed is NLRP3; the disease is Parkinson disease.